Current status of prognostication in classical Hodgkin lymphoma

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†

(2013) C. Martínez et al.   ANNALS OF ONCOLOGY

Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival

(2013) G. Venkataraman et al.   BLOOD

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

(2013) P. Greaves et al.   BLOOD

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma

(2013) J. Ouyang et al.   BLOOD

MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

(2013) Beatriz Sánchez-Espiridión et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma

(2013) P. R. Marri et al.   CLINICAL CANCER RESEARCH

Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma

(2013) K. Jones et al.   CLINICAL CANCER RESEARCH

Tumor associated macrophages and neutrophils in cancer

(2013) Maria Rosaria Galdiero et al.   IMMUNOBIOLOGY

Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis

(2013) Nicole Skoetz et al.   LANCET ONCOLOGY

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

(2013) Sally Arai et al.   LEUKEMIA & LYMPHOMA

The Tumor Microenvironment: A Pitch for Multiple Players

(2013) Giovanna Schiavoni et al.   Frontiers in Oncology

Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma

(2012) Maike Sauer et al.   AMERICAN JOURNAL OF HEMATOLOGY

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

(2012) K. L. Tan et al.   BLOOD

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma

(2012) E. Tiacci et al.   BLOOD

Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma

(2012) C. Steidl et al.   BLOOD

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

(2012) M. R. Green et al.   CLINICAL CANCER RESEARCH

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

(2012) Alden A. Moccia et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression–Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin Lymphoma

(2012) David W. Scott et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome

(2012) Paul Greaves et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

(2012) Andreas Engert et al.   LANCET

State of the art in the treatment of Hodgkin lymphoma

(2012) Peter Borchmann et al.   Nature Reviews Clinical Oncology

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

(2011) Carrie A. Thompson et al.   AMERICAN JOURNAL OF HEMATOLOGY

Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma

(2011) P. Kamper et al.   BLOOD

The Viral Load of Epstein-Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma

(2011) S. Hohaus et al.   CLINICAL CANCER RESEARCH

Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma

(2011) W. J. Plattel et al.   HAEMATOLOGICA

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2011) A. Sureda et al.   HAEMATOLOGICA

Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment

(2011) Christian Steidl et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma

(2011) Maria Kowalska et al.   MEDICAL ONCOLOGY

Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma

(2011) Alexandar Tzankov et al.   PATHOBIOLOGY

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

(2010) B. Sanchez-Espiridion et al.   BLOOD

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

(2010) A. J. Moskowitz et al.   BLOOD

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

(2010) C. Steidl et al.   BLOOD

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

(2010) Björn Lamprecht et al.   NATURE MEDICINE

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

(2010) Anas Younes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does Rituximab Have a Place in Treating Classic Hodgkin Lymphoma?

(2010) Yasuhiro Oki et al.   Current Hematologic Malignancy Reports

The Role of Cytotoxic and Regulatory T cells in Relapsed/Refractory Hodgkin Lymphoma

(2010) Aashiyana F. Koreishi et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma

(2009) Roland Schmitz et al.   Annual Review of Pathology-Mechanisms of Disease

Circulating clonotypic B cells in classic Hodgkin lymphoma

(2009) R. J. Jones et al.   BLOOD

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell linesversusCD77+B-cells reveals a distinct subset of differentially expressed miRNAs

(2009) Pieter Van Vlierberghe et al.   BRITISH JOURNAL OF HAEMATOLOGY

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

(2009) Alison J. Moskowitz et al.   BRITISH JOURNAL OF HAEMATOLOGY

A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples

(2009) B. Sanchez-Espiridion et al.   CLINICAL CANCER RESEARCH

Molecular biology of Hodgkin lymphoma

(2009) R. Kuppers   Hematology-American Society of Hematology Education Program

Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

(2008) D. Buglio et al.   BLOOD

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

(2008) A. Bashey et al.   BLOOD

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

(2008) R. Yamamoto et al.   BLOOD

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

(2008) B. Chetaille et al.   BLOOD

Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization

(2008) S. Hartmann et al.   HAEMATOLOGICA

Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma

(2008) Sabine Schreck et al.   HEMATOLOGICAL ONCOLOGY

Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

(2008) Verena Brune et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Direct multiplexed measurement of gene expression with color-coded probe pairs

(2008) Gary K Geiss et al.   NATURE BIOTECHNOLOGY